A Look At Jazz Pharmaceuticals (JAZZ) Valuation As New Oncology Data Heads To The 2026 AACR Meeting [Yahoo! Finance]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Yahoo! Finance
Event driven spotlight on Jazz Pharmaceuticals Jazz Pharmaceuticals (JAZZ) is back on investor radars after announcing it will share new clinical and preclinical data for several oncology pipeline drugs at the 2026 American Association for Cancer Research Annual Meeting. See our latest analysis for Jazz Pharmaceuticals. The upcoming AACR oncology data arrives after a mixed price pattern, with a 30 day share price return of 8.5% and a year to date gain of 4.22%. At the same time, the 1 year total shareholder return sits at 27.01%, pointing to momentum that has built over the longer term despite recent short term softness. If this kind of pipeline news has your attention, it can be a good moment to scan for other healthcare names using AI in drug development and diagnostics, starting with 35 healthcare AI stocks With shares up 27.0% over the past year and trading at a discount to the average analyst price target, the real question is whether Jazz is still underappreciated or
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- Jazz Pharmaceuticals (JAZZ) had its price target raised by Piper Sandler from $219.00 to $232.00. They now have an "overweight" rating on the stock.MarketBeat
- Jazz Pharmaceuticals to present clinical, preclinical data at AACR 2026 [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026 [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026PR Newswire
- Jazz Pharmaceuticals plc (JAZZ) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
JAZZ
Earnings
- 2/24/26 - Beat
JAZZ
Sec Filings
- 3/9/26 - Form 4
- 3/9/26 - Form 4
- 3/9/26 - Form 4
- JAZZ's page on the SEC website